메뉴 건너뛰기




Volumn 22, Issue 1, 2008, Pages 64-74

International ethical regulations on placebo-use in clinical trials: A comparative analysis

Author keywords

Ethical acceptability; International regulations; Placebo control; Research ethics

Indexed keywords

PLACEBO;

EID: 37249011993     PISSN: 02699702     EISSN: 14678519     Source Type: Journal    
DOI: 10.1111/j.1467-8519.2007.00587.x     Document Type: Article
Times cited : (32)

References (26)
  • 1
    • 33748544772 scopus 로고    scopus 로고
    • The European Group on Ethics in Science and New Technologies to the European Commission. Luxembourg: Office for Official Publications of the European Communities.
    • The European Group on Ethics in Science and New Technologies to the European Commission. 2003. Opinion on the ethical aspects of research in developing countries. Luxembourg: Office for Official Publications of the European Communities.
    • (2003) Opinion on the Ethical Aspects of Research in Developing Countries
  • 4
    • 37249036724 scopus 로고    scopus 로고
    • See Section 5. The availability of proven treatment as a condition for the use of placebo.
    • See Section 5. The availability of proven treatment as a condition for the use of placebo.
  • 5
    • 37249084215 scopus 로고    scopus 로고
    • World Medical Association. 2002. Declaration of Helsinki.
    • World Medical Association. 2002. Declaration of Helsinki.
  • 6
    • 0003433351 scopus 로고    scopus 로고
    • Council for International Organizations of Medical Sciences CIOMS in collaboration with the World Health Organization. Geneva.
    • Council for International Organizations of Medical Sciences CIOMS in collaboration with the World Health Organization. 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva.
    • (2002) International Ethical Guidelines for Biomedical Research Involving Human Subjects
  • 7
    • 37249009339 scopus 로고    scopus 로고
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Choice of Control Group and Related Issues in Clinical Trials. E 10.
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2000. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials. E 10.
    • (2000) ICH Harmonised Tripartite Guideline
  • 10
    • 0030775618 scopus 로고    scopus 로고
    • The Ethics of Clinical Research in the Third World
    • M. Angell. The Ethics of Clinical Research in the Third World. NEJM 1997; 337: 847-849.
    • (1997) NEJM , vol.337 , pp. 847-849
    • Angell, M.1
  • 11
    • 0030228704 scopus 로고    scopus 로고
    • Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths
    • B. Freedman et al. Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths. JLME 1996; 24: 243-251.
    • (1996) JLME , vol.24 , pp. 243-251
    • Freedman, B.1
  • 12
    • 0034641552 scopus 로고    scopus 로고
    • For and against
    • K.J. Rothmann et al. For and against. BMJ 2000; 321: 442-445.
    • (2000) BMJ , vol.321 , pp. 442-445
    • Rothmann, K.J.1
  • 13
    • 37249083668 scopus 로고    scopus 로고
    • We are only using simplified formulations of each criterion to illustrate each principle with an example. These formulations are neither exactly corresponding to one of the guidelines nor to our preferences for detailed, elaborated ethical principles.
    • We are only using simplified formulations of each criterion to illustrate each principle with an example. These formulations are neither exactly corresponding to one of the guidelines nor to our preferences for detailed, elaborated ethical principles.
  • 14
    • 0028070548 scopus 로고
    • The Continuing Unethical Use of Placebo Controls
    • K.B. Michels et al. The Continuing Unethical Use of Placebo Controls. NEJM 1994; 331: 394-398.
    • (1994) NEJM , vol.331 , pp. 394-398
    • Michels, K.B.1
  • 15
    • 2942512903 scopus 로고    scopus 로고
    • The revision of the Declaration of Helsinki: Past, present and future
    • Cf. e.g.
    • Cf. e.g. R.V. Carlson et al. The revision of the Declaration of Helsinki: past, present and future. BrJClinPharmacol 2004; 57: 700.
    • (2004) BrJClinPharmacol , vol.57 , pp. 700
    • Carlson, R.V.1
  • 16
    • 0037389433 scopus 로고    scopus 로고
    • Update on unethical use of placebos in randomised trials
    • E.g.
    • E.g. K. Michels et al. Update on unethical use of placebos in randomised trials. Bioethics 2003; 17: 188-204.
    • (2003) Bioethics , vol.17 , pp. 188-204
    • Michels, K.1
  • 17
    • 2342428820 scopus 로고    scopus 로고
    • The standard of care debate: The Declaration of Helsinki versus the international consensus opinion
    • This is the opinion of
    • This is the opinion of R.K. Lie et al. The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics 2004; 30: 190.
    • (2004) J Med Ethics , vol.30 , pp. 190
    • Lie, R.K.1
  • 18
    • 0037312999 scopus 로고    scopus 로고
    • The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia
    • E.g.
    • E.g. W.T. Carpenter et al. The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia. AmJPsych 2003; 160: 356-362.
    • (2003) AmJPsych , vol.160 , pp. 356-362
    • Carpenter, W.T.1
  • 20
    • 0033558325 scopus 로고    scopus 로고
    • Placebo-controlled trials in shizophrenia: Are they ethical? Are they necessary
    • Michels, op. cit. note 13.
    • C. Weijer. Placebo-controlled trials in shizophrenia: Are they ethical? Are they necessary. Schizophrenia Research 1999; 35: 211-218. Michels, op. cit. note 13.
    • (1999) Schizophrenia Research , vol.35 , pp. 211-218
    • Weijer, C.1
  • 21
    • 37249059070 scopus 로고    scopus 로고
    • Freedman, op. cit. note 10, p. 24.
    • Freedman, op. cit. note 10, p. 24.
  • 22
    • 37249025873 scopus 로고    scopus 로고
    • Freedman, op. cit. note 10.
    • Freedman, op. cit. note 10.
  • 23
    • 37249086365 scopus 로고    scopus 로고
    • Macklin, op. cit. note 17.
    • Macklin, op. cit. note 17.
  • 24
    • 37249092205 scopus 로고    scopus 로고
    • The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1, 2.10 The use of placebo.
    • The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1, 2.10 The use of placebo.
  • 25
    • 37249028377 scopus 로고    scopus 로고
    • The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1.
    • The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1.
  • 26
    • 0342657088 scopus 로고    scopus 로고
    • Protecting the vulnerable: Testing times for clinical research ethics
    • Macklin op. cit. note 18.
    • U. Schüklenk. Protecting the vulnerable: testing times for clinical research ethics. Social Science and Medicine 2000; 51: 969-977. Macklin op. cit. note 18.
    • (2000) Social Science and Medicine , vol.51 , pp. 969-977
    • Schüklenk, U.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.